Journal:
:medical journal of islamic republic of iran
0
mahdi shahriari pediatric hematology – oncology department, nemazee hospital, shiraz university of medical sciences, shiraz, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی شیراز (shiraz university of medical sciences)سازمان های دیگر: nemazee hospital,
sezaneh haghpanah hematology research center, shiraz university of medical sciences, shiraz, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی شیراز (shiraz university of medical sciences)سازمان های دیگر: hematology research center
javad dehghani hematology research center, shiraz university of medical sciences, shiraz, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی شیراز (shiraz university of medical sciences)سازمان های دیگر: hematology research center
javad dehbozorgian hematology research center, shiraz university of medical sciences, shiraz, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی شیراز (shiraz university of medical sciences)سازمان های دیگر: hematology research center
peyman eatemadfar hematology research center, shiraz university of medical sciences, shiraz, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی شیراز (shiraz university of medical sciences)سازمان های دیگر: hematology research center
asghar bazrafshan hematology research center, shiraz university of medical sciences, shiraz, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی شیراز (shiraz university of medical sciences)سازمان های دیگر: hematology research center
background :highserum level of cancer antigen 15.3 (ca15.3) has been reported in some malignant and nonmalignant conditions including thalassemia major which could have been resulted from ineffective erythropoiesis. we aimed to evaluate the serum level of ca15.3 in carriers of beta-thalassemia by comparing them with cancer patients and healthy individuals. methods : this cross-sectional study...